Provision of unapproved medicines for unmet medical needs
We recognise that there may be instances when Healthcare Professionals seek an unapproved medicine or vaccine for a patient that has no other satisfactory alternative treatment options. GSK has established programs that may provide an option for providers faced with these challenges.
Provision of unapproved medicines under these circumstances may be referred to by various names depending country regulations (e.g. single patient use, named patient use, compassionate use, expanded access, special access, managed access, importation of unlicensed medicine, etc.).
Healthcare professional requests for unapproved medicines
If you are a Healthcare Professional who would like to request a GSK medicine that is not approved, licensed or available in your country for treatment of a patient, please make a request via the GSK Managed Access Request Portal. Only Healthcare Professionals can submit a request, which requires creation of a profile.
We are currently transitioning to a new managed access request portal.
From the 5th of October 2026:
- For new managed access requests please visit: https://ea.medasystems.com/intake/gsk-viiv to submit a request, and ea.medasystems.com to view these requests.
- For updating historical requests made in the old portal (e.g. resupplies) please visit: Compassionate Use (Expanded Access)
In order to handle your enquiry, GSK is required to record and maintain the personal information provided, including your name and contact details. This personal information will be processed solely for the purpose of dealing with this enquiry. More detailed information on the processing of your personal information is available from our Privacy Notice.
